Bosh sahifaGRF • VIE
add
Grifols SA Class A
Yopilish kursi
10,74 €
Kunlik diapazon
9,41 € - 9,81 €
Yillik diapazon
6,58 € - 15,51 €
Bozor kapitalizatsiyasi
6,27 mlrd EUR
Oʻrtacha hajm
4,00
Narx/foyda
46,83
Dividend daromadliligi
-
Asosiy maydon
BME
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,79 mlrd | 12,24% |
Joriy xarajat | 376,78 mln | -3,08% |
Sof foyda | 51,69 mln | -13,19% |
Sof foyda marjasi | 2,88 | -22,79% |
Har bir ulushga tushum | — | — |
EBITDA | 468,09 mln | 33,73% |
Amaldagi soliq stavkasi | 31,35% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 806,74 mln | 66,60% |
Jami aktivlari | 20,28 mlrd | -8,07% |
Jami passivlari | 12,29 mlrd | -8,95% |
Umumiy kapital | 8,00 mlrd | — |
Tarqatilgan aksiyalar | 679,63 mln | — |
Narxi/balansdagi bahosi | 1,36 | — |
Aktivlardan daromad | 4,22% | — |
Kapitaldan daromad | 4,78% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 51,69 mln | -13,19% |
Operatsiyalardan naqd pul | 299,61 mln | 92,51% |
Sarmoyadan naqd pul | -196,40 mln | -59,83% |
Moliyadan naqd pul | -1,56 mlrd | -1 860,81% |
Naqd pulning sof oʻzgarishi | -1,47 mlrd | -3 652,69% |
Boʻsh pul | 243,60 mln | 627,76% |
Haqida
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. Wikipedia
Tashkil etilgan
18-noy, 1940
Sayt
Xodimlar soni
23 000
